Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Gynecological Surgery

Fig. 4

From: HMG-CoA reductase inhibitor lovastatin upregulates plasminogen activator production through RhoA-signaling in peritoneal cell line Met5A

Fig. 4

RhoA activity in Met5A cells exposed to lovastatin. Met5A cells were exposed to lovastatin (1 µM), lovastatin and geranylgeranyl pyrophosphate (GGPP; 1 µM), C3 (1 µg/ml), or lovastatin, GGPP, and C3 for 18 h. Values are expressed as means optical density (490 nm) ± SD of three independent experiments performed in duplicate determination. *P < 0.05 versus control

Back to article page